Class ITerminatedD-0631-2022
Drug recall · February 23, 2022
365 SKINNY High Intensity Capsules recall
Why: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL
- Lots / codes
Lot 102-26, Exp Dec 2022
- Quantity
- 783 bottles
- Company
- Je Dois Lavoir LLC, Visalia, CA
- Distribution
- Sold online via website nationwide in the USA and Canada.
- Initiated
- August 2, 2021 · Voluntary: Firm initiated
- Classified
- February 23, 2022
- Reported
- February 23, 2022
- Ended
- May 2, 2023
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.